Trial Profile
Phase II trial of CP 870893 in patients with cancer.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2012
Price :
$35
*
At a glance
- Drugs CP 870893 (Primary)
- Indications Cancer
- Focus Therapeutic Use
- Sponsors VLST Corporation
- 03 Sep 2012 New trial record